Case number 2016-1785
Shire Development, LLC v. Watson Laboratories, Inc. - FL > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | SHIRE DEVELOPMENT, LLC v. WATSON PHARMACEUTICALS, INC. [OPINION] [precedential] (0) |
| May 18, 2017 | 90 | Mandate issued to the United States District Court for the Southern District of Florida. Service as of this date by Clerk of Court. [432456] [SJ] [Entered: 05/18/2017 09:21 AM] (1) |
| May 10, 2017 | 89 | ORDER filed denying combined petition for rehearing [70] filed by Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Giuliani International Limited. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [430205] [MJL] [Entered: 05/10/2017 09:31 AM] (2) |
| May 1, 2017 | 88 | 18 paper copies of the response [86] received from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida and Watson Pharma, Inc. [428284] [MJL] [Entered: 05/01/2017 03:26 PM] (0) |
| May 1, 2017 | 87 | Notice to counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida and Watson Pharma, Inc.: The record of this case indicates that the paper copies of response to rehearing petition (see Fed. Cir. R. 35(c)(4)) have not been filed. Please file promptly. Service as of this date by Clerk of Court. [428173] [JB] [Entered: 05/01/2017 12:01 PM] (0) |
| Apr 24, 2017 | 86 | RESPONSE of Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida and Watson Pharma, Inc. to the petition for panel rehearing [70] filed by Appellees Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Giuliani International Limited in 16-1785 , petition for en banc rehearing [70] filed by Appellees Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Giuliani International Limited in 16-1785. Service: 04/24/2017 by email. [426741] [Scott Bornstein] [Entered: 04/24/2017 07:17 PM] (18) |
| Apr 11, 2017 | 85 | The court invites a response from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida and Watson Pharma, Inc. to the combined petition for rehearing filed by Appellees in 16-1785. [423193] [MJL] [Entered: 04/11/2017 02:47 PM] (1) |
| Apr 11, 2017 | 84 | ORDER filed granting motions to withdraw attorneys [76] and modify the official caption [80] filed by Appellants Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. - Florida. The revised official caption is reflected in the order. By: Per Curiam. Service as of this date by Clerk of Court. [423184] [MJL] [Entered: 04/11/2017 02:26 PM] (2) |
| Mar 31, 2017 | 83 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The entries of appearance [78], [81], [82], certificate of interest [79], and motion to modify the official caption [80] filed by Appellants were not text-searchable. CORRECTION: All documents submitted to the court are required to be text-searchable. Please ensure future filings are entirely text-searchable. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [420677] [MJL] [Entered: 03/31/2017 02:13 PM] (0) |
| Mar 31, 2017 | 82 | Entry of appearance for Richard C. Pettus as of counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/31/2017 by email. [420651] [Richard Pettus] [Entered: 03/31/2017 01:23 PM] (3) |
| Mar 31, 2017 | 81 | Entry of appearance for Jonathan D. Ball as of counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/31/2017 by email. [420648] [Jonathan Ball] [Entered: 03/31/2017 01:18 PM] (3) |
| Mar 31, 2017 | 80 | MOTION of Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. to modify the official caption. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/31/2017 by email. [420647] [Scott Bornstein] [Entered: 03/31/2017 01:13 PM] (6) |
| Mar 31, 2017 | 79 | Certificate of Interest for the Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/31/2017 by email. [420643] [Scott Bornstein] [Entered: 03/31/2017 01:07 PM] (3) |
| Mar 31, 2017 | 78 | Entry of appearance for Scott J. Bornstein as principal counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/31/2017 by email. [420642] [Scott Bornstein] [Entered: 03/31/2017 01:05 PM] (3) |
| Mar 22, 2017 | 77 | NOTICE OF DEFICIENCY: The entries of appearance for Scott J. Bornstein [72], Richard C. Pettus [74], and Jonathan D. Ball [75] filed by Appellants in 16-1785 cannot be accepted for filing at this time. The EOAs indicate counsel are only representing Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, and Watson Pharma, Inc., but the docket text reflects that they are also representing Watson Pharmaceuticals, Inc.. You are being afforded the opportunity to correct the deficiency. When submitting corrected EOAs, please ensure the docket text matches the list of represented parties included on the forms. [417703] [MJL] [Entered: 03/22/2017 08:38 AM] (0) |
| Mar 17, 2017 | 76 | MOTION of Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. to withdraw counsel Steven A. Maddox, Jeremy J. Edwards, and Kaveh Saba. Any response is due within 10 days of service [Consent: not addressed]. Service: 03/17/2017 by email. [416709] [Steven Maddox] [Entered: 03/17/2017 04:17 PM] (6) |
| Mar 16, 2017 | 75 | Entry of appearance for Jonathan D. Ball as of counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416436] [Jonathan Ball] [Entered: 03/16/2017 10:41 PM] (0) |
| Mar 16, 2017 | 74 | Entry of appearance for Richard C. Pettus as of counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416435] [Richard Pettus] [Entered: 03/16/2017 10:34 PM] (0) |
| Mar 16, 2017 | 73 | Certificate of Interest for the Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416434] [Scott Bornstein] [Entered: 03/16/2017 10:24 PM] (3) |
| Mar 16, 2017 | 72 | Entry of appearance for Scott J. Bornstein as principal counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416432] [Scott Bornstein] [Entered: 03/16/2017 10:22 PM] (0) |
| Mar 14, 2017 | 71 | 18 paper copies of the petition for panel rehearing [70], petition for en banc rehearing [70] received from Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. [415558] [SJ] [Entered: 03/15/2017 08:59 AM] (0) |
| Mar 13, 2017 | 70 | Petition for panel rehearing, for en banc rehearing filed by Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 03/13/2017 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 03/15/2017 [415070] [Edgar Haug] [Entered: 03/13/2017 05:21 PM] (35) |
| Mar 3, 2017 | 69 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The firm information included on the entries of appearance for Jason A. Lief [65], Erika Selli [66], and Andrew Wasson [68] does not match the information in the attorneys' user accounts. CORRECTION: Please update as needed to ensure the contact information on the entries of appearance and in the user accounts matches. [412210] [MJL] [Entered: 03/03/2017 09:08 AM] (0) |
| Mar 2, 2017 | 68 | Amended Entry of appearance for Andrew Wasson as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 03/02/2017 by email. [411942] [Andrew Wasson] [Entered: 03/02/2017 11:51 AM] (3) |
| Mar 2, 2017 | 67 | Amended Entry of appearance for Elizabeth Murphy as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 03/02/2017 by email. [411932] [Elizabeth Murphy] [Entered: 03/02/2017 11:39 AM] (3) |
| Mar 2, 2017 | 66 | Amended Entry of appearance for Erika Selli as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 03/02/2017 by email. [411928] [Erika Selli] [Entered: 03/02/2017 11:36 AM] (3) |
| Mar 2, 2017 | 65 | Amended Entry of appearance for Jason A. Lief as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 03/02/2017 by email. [411920] [Jason Lief] [Entered: 03/02/2017 11:25 AM] (3) |
| Mar 2, 2017 | 64 | Amended Entry of appearance for Edgar H. Haug as principal counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 03/02/2017 by email. [411919] [Edgar Haug] [Entered: 03/02/2017 11:23 AM] (3) |
| Mar 2, 2017 | 63 | Amended Certificate of Interest for the Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 03/02/2017 by email. [411918] [Edgar Haug] [Entered: 03/02/2017 11:21 AM] (3) |
| Feb 10, 2017 | 62 | OPINION and JUDGMENT filed. The judgment or decision is: Reversed and Remanded. (Precedential Opinion). (For the Court: Prost,Chief Judge; Taranto,Circuit Judge and Hughes,Circuit Judge). [406309] [MJL] [Entered: 02/10/2017 09:07 AM] (13) |
| Nov 7, 2016 | 61 | RESPONSE of Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. to the supplemental authority [60] filed by Appellees Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Giuliani International Limited in 16-1785. Service: 11/07/2016 by email. [381077] [Steven Maddox] [Entered: 11/07/2016 07:28 PM] (3) |
| Nov 1, 2016 | 60 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 11/01/2016 by email. [379439] [Edgar Haug] [Entered: 11/01/2016 04:54 PM] (3) |
| Oct 5, 2016 | 59 | Submitted after ORAL ARGUMENT by Steven Arthur Maddox for Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. - Florida and Edgar Haug for Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Giuliani International Limited. Panel: Judge: Prost , Judge: Taranto , Judge: Hughes. [372121] [JAB] [Entered: 10/06/2016 10:18 AM] (0) |
| Oct 3, 2016 | 58 | RESPONSE of Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. to the supplemental authority [56] filed by Appellants Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. - Florida in 16-1785. Service: 08/03/2016 by email. [371098] [Edgar Haug] [Entered: 10/03/2016 05:53 PM] (3) |
| Oct 3, 2016 | 57 | Amended Certificate of Interest for the Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 10/03/2016 by email. [370832] [Steven Maddox] [Entered: 10/03/2016 11:19 AM] (4) |
| Sep 29, 2016 | 56 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 09/29/2016 by email. [370112] [Steven Maddox] [Entered: 09/29/2016 11:12 AM] (50) |
| Sep 14, 2016 | 55 | Response to oral argument order from the Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. designating Edgar H. Haug as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [366465] [Edgar Haug] [Entered: 09/14/2016 05:18 PM] (0) |
| Sep 13, 2016 | 54 | Response to oral argument order from the Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. designating Steven A. Maddox as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [366103] [Steven Maddox] [Entered: 09/13/2016 11:42 AM] (0) |
| Aug 29, 2016 | 53 | RESPONSE of Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. to the supplemental authority [51] filed by Appellants Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. - Florida in 16-1785. Service: 08/29/2016 by email. [362824] [Edgar Haug] [Entered: 08/29/2016 05:41 PM] (3) |
| Aug 19, 2016 | 52 | NOTICE OF CALENDARING. Panel: 1610C. Case scheduled Oct 05, 2016 10:00 a.m. at the Loyola Law School (Loyola Marymount University, 919 Albany Street Los Angeles, CA 90015), Robinson Courtroom. Response to oral argument order due: 09/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [360509] THIS NOTICE APPLIES TO CASE(S): [16-1208, 16-1216, 16-1278, 16-1785] [JAB] [Entered: 08/19/2016 04:30 PM] (0) |
| Aug 15, 2016 | 51 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 08/15/2016 by email. [358915] [Steven Maddox] [Entered: 08/15/2016 04:04 PM] (3) |
| Jul 29, 2016 | 50 | **TEXT ONLY** ORDER granting motion to withdraw attorney [49] filed by Appellees Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Giuliani International Limited. Caroline Bercier is withdrawn as counsel for Appellees. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [354718] [MJL] [Entered: 07/29/2016 04:00 PM] (0) |
| Jul 29, 2016 | 49 | MOTION of Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. to withdraw counsel Caroline Bercier. Response/Opposition is due 08/11/2016 [Consent: unopposed]. Service: 07/29/2016 by email. [354573] [Edgar Haug] [Entered: 07/29/2016 12:01 PM] (6) |
| Jul 13, 2016 | 47 | Notice from Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. regarding conflicts with oral argument (September 6-9, 2016; October 13-14 and 17, 2016). Service: 07/13/2016 by email. [350388] [Edgar Haug] [Entered: 07/13/2016 09:43 AM] (2) |
| Jul 12, 2016 | 46 | Notice from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. regarding conflicts with oral argument (August 11-31, 2016). Service: 07/12/2016 by email. [350287] [Steven Maddox] [Entered: 07/12/2016 04:09 PM] (1) |
| Jul 12, 2016 | 48 | 6 paper copies of the Joint Appendix [42] received from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. [350408] [KW] [Entered: 07/13/2016 10:01 AM] (0) |
| Jul 8, 2016 | 45 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [349368] [LN] [Entered: 07/08/2016 11:49 AM] (0) |
| Jul 6, 2016 | 44 | 6 CD-ROM's of the Opening Brief received from Appellees Shire Development, LLC, Shire Pharmaceutical Development, Inc., Cosmo Technologies Limited, and Giuliani Internationa Limited. (Ref: Opening Response Brief , [33]) [348792] [JCP] [Entered: 07/06/2016 01:24 PM] (0) |
| Jul 6, 2016 | 43 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice of Conflict with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/13/2016. [348684] [MJL] [Entered: 07/06/2016 11:10 AM] (0) |
| Jul 5, 2016 | 42 | APPENDIX FILED for Watson Laboratories, Inc. et al. [39]. Number of Pages: 349. Service: 07/05/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the appendix in paper format. The paper copies should be received by the court on or before 07/11/2016. [348675] [MJL] [Entered: 07/06/2016 11:01 AM] (349) |
| Jul 5, 2016 | 41 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 07/05/2016 by email. [348548] [Steven Maddox] [Entered: 07/05/2016 06:00 PM] (3) |
| Jul 5, 2016 | 40 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/05/2016 by email. [348545] [Edgar Haug] [Entered: 07/05/2016 05:39 PM] (3) |
| Jul 5, 2016 | 39 | TENDERED from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc., Watson Pharmaceuticals, Inc. and Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Title: JOINT APPENDIX. Service: 07/05/2016 by email. [348537] [Steven Maddox] [Entered: 07/05/2016 05:11 PM] (349) |
| Jul 5, 2016 | 38 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc., Watson Pharmaceuticals, Inc. and Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/05/2016 by email. [348465] [Steven Maddox] [Entered: 07/05/2016 03:19 PM] (3) |
| Jul 1, 2016 | 37 | 6 paper copies of the Reply Brief [36] received from Appellants Watson Laboratories, Inc. et al. [348062] [MJL] [Entered: 07/01/2016 11:19 AM] (0) |
| Jun 27, 2016 | 36 | REPLY BRIEF FILED for Appellants Watson Laboratories, Inc. et al. [35]. Number of Pages: 28. Service: 06/27/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/05/2016. Appendix is due 07/08/2016. [346874] [MJL] [Entered: 06/28/2016 09:05 AM] (35) |
| Jun 27, 2016 | 35 | TENDERED from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Title: REPLY BRIEF. Service: 06/27/2016 by email. [346691] [Steven Maddox] [Entered: 06/27/2016 02:04 PM] (35) |
| Jun 15, 2016 | 34 | 6 paper copies of the Opening Response Brief [33] received from Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. [343893] [KW] [Entered: 06/15/2016 03:40 PM] (0) |
| Jun 13, 2016 | 33 | BRIEF FILED for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. [32]. Number of Pages: 58. Service: 06/13/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/20/2016. Reply Brief of Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. is due 06/27/2016. [343327] [MJL] [Entered: 06/14/2016 11:35 AM] (71) |
| Jun 13, 2016 | 32 | TENDERED from Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Title: RESPONSE BRIEF. Service: 06/13/2016 by email. [343145] [Edgar Haug] [Entered: 06/13/2016 06:56 PM] (71) |
| Jun 2, 2016 | 31 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Andrew Wasson (entry of appearance [29]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. [340143] [MJL] [Entered: 06/02/2016 08:55 AM] (0) |
| Jun 1, 2016 | 30 | Corrected Entry of appearance for Jason A. Lief as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 06/01/2016 by email. [340083] [Edgar Haug] [Entered: 06/01/2016 05:22 PM] (3) |
| Jun 1, 2016 | 29 | Entry of appearance for Andrew Wasson as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 06/01/2016 by email. [340072] [Edgar Haug] [Entered: 06/01/2016 05:08 PM] (3) |
| Jun 1, 2016 | 28 | Entry of appearance for Jason A. Lief as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 06/01/2016 by email. [340071] [Edgar Haug] [Entered: 06/01/2016 05:06 PM] (1) |
| May 17, 2016 | 27 | ORDER granting motion to modify the official caption [26] filed by Appellees Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Giuliani International Limited. The revised official caption is reflected in the order. Service: 05/17/2016 by clerk. [335840] [NL] [Entered: 05/17/2016 11:04 AM] (2) |
| May 11, 2016 | 26 | MOTION of Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. to modify the official caption. Response/Opposition is due 05/26/2016 [Consent: unopposed]. Service: 05/11/2016 by email. [334319] [Elizabeth Murphy] [Entered: 05/11/2016 04:15 PM] (6) |
| May 11, 2016 | 25 | Notice of intent to file corresponding briefs on CD-ROM for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 05/11/2016 by email. [334317] [Elizabeth Murphy] [Entered: 05/11/2016 04:06 PM] (3) |
| May 11, 2016 | 23 | Entry of appearance for Erika Selli as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 05/11/2016 by email. [334134] [Erika Selli] [Entered: 05/11/2016 11:56 AM] (3) |
| May 11, 2016 | 22 | NOTICE OF DEFICIENCY: The attorney entry of appearance for Erika Selli [21] filed by Appellees in 16-1785 is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [334078] [Corrected party type]--[Edited 05/11/2016 by ALT] [MJL] [Entered: 05/11/2016 10:24 AM] (0) |
| May 11, 2016 | 21 | Entry of appearance for Erika Selli as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 05/11/2016 by email. [334025] [Erika Selli] [Entered: 05/11/2016 09:20 AM] (0) |
| May 10, 2016 | 24 | 6 paper copies of the Opening Brief [19] received from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. [334235] [JCP] [Entered: 05/11/2016 02:24 PM] (0) |
| May 5, 2016 | 20 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Appellants' Brief [18], ERROR: Pages Appx0036 - Appx0039 of the addendum were not text-searchable. CORRECTION: For future filings, please ensure the entire document is text-searchable. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [332406] [MJL] [Entered: 05/05/2016 09:54 AM] (0) |
| May 4, 2016 | 19 | BRIEF FILED for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc., and Watson Pharmaceuticals, Inc. [18]. Number of Pages: 63. Service: 05/04/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/10/2016. Brief of Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC, and Shire Pharmaceutical Development, Inc. is due 06/13/2016. [332405] --[Edited 05/09/2016 by clerk to correc the due date for the appellees brief] [MJL] [Entered: 05/05/2016 09:51 AM] (116) |
| May 4, 2016 | 18 | TENDERED from Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Title: OPENING BRIEF. Service: 05/04/2016 by email. [332263] [Steven Maddox] [Entered: 05/04/2016 03:42 PM] (116) |
| Apr 18, 2016 | 17 | Docketing Statement for the Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 04/18/2016 by email. [327315] [Edgar Haug] [Entered: 04/18/2016 05:45 PM] (8) |
| Apr 18, 2016 | 16 | Certificate of Interest for the Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 04/18/2016 by email. [327313] [Edgar Haug] [Entered: 04/18/2016 05:42 PM] (4) |
| Apr 18, 2016 | 15 | Docketing Statement for the Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 04/18/2016 by email. [327212] [Steven Maddox] [Entered: 04/18/2016 03:39 PM] (8) |
| Apr 6, 2016 | 14 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance in Docket No. [12] and attorney entry of appearance in Docket No. [13], ERROR: Attornies Elizabeth J. Murphy and Caroline Bercier are not registered CM/ECF filers. CORRECTION: Pursuant to FCR 25(a2), please register for this court's CM/ECF system. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [324425] [MJL] [Entered: 04/06/2016 11:46 AM] (0) |
| Apr 6, 2016 | 13 | Entry of appearance for Caroline Bercier as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 04/06/2016 by email. [324391] [Edgar Haug] [Entered: 04/06/2016 11:16 AM] (3) |
| Apr 6, 2016 | 12 | Entry of appearance for Elizabeth Murphy as of counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 04/06/2016 by email. [324388] [Edgar Haug] [Entered: 04/06/2016 11:12 AM] (3) |
| Apr 6, 2016 | 11 | Entry of appearance for Edgar H. Haug as principal counsel for Appellees Cosmo Technologies Limited, Giuliani International Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 04/06/2016 by email. [324387] [Edgar Haug] [Entered: 04/06/2016 11:11 AM] (3) |
| Apr 6, 2016 | 10 | ORDER filed. The motion [7] is denied. The appellants may of course self-expedite the briefing schedule by filing their own briefs and the joint appendix early. The case will be scheduled on the next available calendar after the reply brief is filed. (Per Curiam). Service: 04/06/2016 by clerk. [324287] [LMS] [Entered: 04/06/2016 07:42 AM] (2) |
| Apr 5, 2016 | 9 | Corrected Certificate of Interest for the Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 04/05/2016 by email. [324018] [Steven Maddox] [Entered: 04/05/2016 12:31 PM] (3) |
| Apr 5, 2016 | 8 | NOTICE OF DEFICIENCY: The certificate of interest (Document No. [6]) filed by Appellants Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. - Florida in 16-1785 is submitted using an outdated form and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [323873] [MJL] [Entered: 04/05/2016 08:46 AM] (0) |
| Apr 4, 2016 | 7 | MOTION of Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. to expedite briefing schedule. Response/Opposition is due 04/18/2016, to expedite hearing. Response/Opposition is due 04/18/2016 [Consent: opposed]. Service: 04/04/2016 by email. [323803] [Steven Maddox] [Entered: 04/04/2016 05:25 PM] (50) |
| Apr 4, 2016 | 6 | Certificate of Interest for the Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 04/04/2016 by email. [323801] [Steven Maddox] [Entered: 04/04/2016 05:15 PM] (0) |
| Apr 4, 2016 | 5 | Entry of appearance for Kaveh Saba as of counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 04/04/2016 by email. [323799] [Steven Maddox] [Entered: 04/04/2016 05:13 PM] (3) |
| Apr 4, 2016 | 4 | Entry of appearance for Jeremy J. Edwards as of counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 04/04/2016 by email. [323798] [Steven Maddox] [Entered: 04/04/2016 05:12 PM] (3) |
| Apr 4, 2016 | 3 | Corrected Entry of appearance for Steven A. Maddox as principal counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 04/04/2016 by email. [323797] [Steven Maddox] [Entered: 04/04/2016 05:11 PM] (3) |
| Apr 4, 2016 | 2 | Entry of appearance for Steven A. Maddox as principal counsel for Appellants Watson Laboratories, Inc., Watson Laboratories, Inc. - Florida, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc.. Service: 04/04/2016 by email. [323786] [Steven Maddox] [Entered: 04/04/2016 04:58 PM] (0) |
| Apr 4, 2016 | 1 | Appeal docketed. Received: 03/29/2016. [323570]Entry of Appearance due 04/18/2016. Certificate of Interest is due on 04/18/2016. Docketing Statement due 04/18/2016. Appellant/Petitioner's brief is due 06/03/2016. [MJL] [Entered: 04/04/2016 12:12 PM] (108) |
